Selective serotonin reuptake inhibitor exposure in pregnancy and neonatal adverse events.
Dubnov-Raz
Gal
G
Koren
Gideon
G
Finkelstein
Yaron
Y
D000818:Animals; D005260:Female; D005318:Fetal Heart / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D008133:Long QT Syndrome / Q000139:chemically induced*; D051379:Mice; D018345:Mice, Knockout; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced*; D050486:Serotonin Plasma Membrane Transport Proteins / Q000378:metabolism*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000494:pharmacology
D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors